High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis.
Yeh S, Wroblewski K, Buggage R, Li Z, Kurup SK, Sen HN, Dahr S, Sran P, Reed GF, Robinson R, Ragheb JA, Waldmann TA, Nussenblatt RB.
Yeh S, et al. Among authors: kurup sk.
J Autoimmun. 2008 Sep;31(2):91-7. doi: 10.1016/j.jaut.2008.05.001. Epub 2008 Jun 20.
J Autoimmun. 2008.
PMID: 18571896
Free PMC article.
Clinical Trial.